Financial reports
10-Q
2024 Q2
Quarterly report
8 Aug 24
10-Q
2024 FY
Quarterly report
9 May 24
ARS
2023 FY
Annual report to shareholders
23 Apr 24
10-K
2023 FY
Annual report
6 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 FY
Quarterly report
8 Aug 23
10-Q
2023 FY
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
26 Apr 23
10-K
2022 FY
Annual report
8 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
Current reports
8-K
Xeris Xeris Biopharma Reports Second Quarter 2024 Financial Results
8 Aug 24
8-K
Departure of Directors or Certain Officers
2 Aug 24
8-K
Xeris Biopharma Announces Ceo Succession Plan
8 Jul 24
8-K
Departure of Directors or Certain Officers
5 Jun 24
8-K
Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events
9 May 24
8-K
Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
6 Mar 24
8-K
Xeris Biopharma Updates Its Outlook for 2023
4 Jan 24
8-K
Xeris Biopharma Reports Third Quarter 2023 Financial Results
9 Nov 23
8-K
Regulation FD Disclosure
16 Oct 23
8-K
Entry into a Material Definitive Agreement
29 Sep 23
Registration and prospectus
S-8
Registration of securities for employees
8 Aug 24
S-8
Registration of securities for employees
6 Mar 24
S-8
Registration of securities for employees
8 Mar 23
424B5
Prospectus supplement for primary offering
11 May 22
S-8
Registration of securities for employees
11 Mar 22
424B3
Prospectus supplement
8 Feb 22
S-3
Shelf registration
28 Jan 22
S-3
Shelf registration
28 Jan 22
S-8
Registration of securities for employees
5 Oct 21
8-K12B
Notification of registration of securities
5 Oct 21
Proxies
DEFA14A
Additional proxy soliciting materials
23 Apr 24
DEF 14A
Definitive proxy
23 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 23
DEF 14A
Definitive proxy
26 Apr 23
DEFA14A
Additional proxy soliciting materials
2 May 22
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
Other
EFFECT
Notice of effectiveness
8 Feb 22
EFFECT
Notice of effectiveness
8 Feb 22
CORRESP
Correspondence with SEC
4 Feb 22
CORRESP
Correspondence with SEC
4 Feb 22
UPLOAD
Letter from SEC
1 Feb 22
UPLOAD
Letter from SEC
1 Feb 22
EFFECT
Notice of effectiveness
30 Jul 21
CORRESP
Correspondence with SEC
28 Jul 21
UPLOAD
Letter from SEC
9 Jul 21